Skip to main content

and
  1. Article

    Open Access

    Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

    We report the levels of neutralising antibodies against Wuhan, Delta and Omicron variants in unimmunized infected (group 1), immunised and boosted (group 2) and infected immunised and boosted (group 3) adult i...

    Kevin K. Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken in npj Vaccines (2022)

  2. Article

    Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

    Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including mRNA, adenoviral-vectored, protein subu...

    Manish Sadarangani, Arnaud Marchant, Tobias R. Kollmann in Nature Reviews Immunology (2021)

  3. Article

    Open Access

    Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants

    Differences in innate immune ‘imprinting’ between vaccine adjuvants may mediate dissimilar effects on the quantity/quality of persisting adaptive responses. We compared antibody avidity maturation, antibody/me...

    Sonia Budroni, Francesca Buricchi, Andrea Cavallone, Patricia Bourguignon in npj Vaccines (2021)

  4. Article

    Breastfeeding-related maternal microchimerism

    Jean-Pierre Molès, Edouard Tuaillon, Chipepo Kankasa in Nature Reviews Immunology (2017)

  5. No Access

    Article

    Do PI3-kinase mutations drive T cells insane?

    David Vermijlen, Michel Y Braun, Arnaud Marchant in Cellular & Molecular Immunology (2014)